MISHTI study evaluating hepatic fibrosis in type 2 diabetes patients in India
Abstract Hepatic fibrosis is a critical complication of metabolic disorders, particularly in patients with Type 2 Diabetes (T2D). This study aimed to evaluate the performance of the Fibrosis 4 index (FIB 4) score in detecting significant fibrosis (transient elastography [TE] ≥ 8 kPa) and identify ke...
Saved in:
| Main Authors: | Debasis Datta, Krishna G. Seshadri, Samit Ghosal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-10871-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Redefining Liver Fibrosis Risk Assessment in Indians with Type 2 Diabetes: New FIB-4 Score Cutoff for Optimizing Sequential Assessment with Transient Elastography
by: Rajat Deb, et al.
Published: (2025-03-01) -
Non-Invasive Tests as a Replacement for Liver Biopsy in the Assessment of MASLD
by: Julia Frączek, et al.
Published: (2025-04-01) -
Economic evaluation of non-invasive test pathways for high-risk metabolic dysfunction-associated steatotic liver disease (MASLD) in the United Kingdom (UK)
by: Zobair M. Younossi, et al.
Published: (2025-07-01) -
Characterizing outcomes in a large cohort of latinx patients with autoimmune hepatitis
by: Eleanor Belilos, et al.
Published: (2025-01-01) -
Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Type 2 Diabetes Mellitus
by: Hilmi Erdem Sümbül, et al.
Published: (2025-03-01)